Protective role of μ opioid receptor activation in intestinal inflammation induced by mesenteric ischemia/reperfusion in mice
Authors:
- 17 July 2012
- journal article
- research article
- Published by Wiley in Journal of Neuroscience Research
- Vol. 90 (11) , 2146-2153
Abstract
Intestinal ischemia is a clinical emergency with high morbidity and mortality. We investigated whether activation of μ opioid receptor (μOR) protects from the inflammation induced by intestinal ischemia and reperfusion (I/R) in mice. Ischemia was induced by occlusion of the superior mesenteric artery (45 min), followed by reperfusion (5 hr). Sham‐operated (SO) and normal (N) mice served as controls. Each group received subcutaneously 1) saline solution, 2) the μOR selective agonist [D‐Ala2, N‐Me‐Phe4, Gly5‐ol]‐enkephalin (DAMGO; 0.01 mg kg−1), 3) DAMGO and the selective μOR antagonist [H‐D‐Phe‐Cys‐Tyr‐D‐Trp‐Arg‐Thr‐Pen‐Thr‐NH2] (CTAP; 0.1 mg kg−1), or 4) CTAP alone. I/R induced intestinal inflammation as indicated by histological damage and the significant increase in myeloperoxidase (MPO) activity, an index of tissue neutrophil accumulation. Tumor necrosis factor‐α (TNF‐α) and interleukin‐10 (IL‐10) mRNA levels were also increased in I/R mice compared with SO. DAMGO significantly reduced tissue damage, MPO activity, and TNF‐α mRNA levels in I/R, and these effects were reversed by CTAP. By contrast, DAMGO did not modify IL‐10 mRNA levels or gastrointestinal transit. DAMGO's effects are receptor mediated and likely are due to activation of peripheral μORs, because it does not readily cross the blood–brain barrier. These findings suggest that activation of peripheral μOR protects from the inflammatory response induced by I/R through a pathway involving the proinflammatory cytokine TNF‐α. Reduction of acute inflammation might prevent I/R complications, including motility impairment, which develop at a later stage of reperfusion and likely are due to inflammatory cell infiltrates.Keywords
This publication has 47 references indexed in Scilit:
- Opioid antagonists for prevention and treatment of opioid-induced gastrointestinal effectsCurrent Opinion in Anaesthesiology, 2010
- Lymphocytes and ischemia-reperfusion injuryTransplantation Reviews, 2009
- Evidence for the involvement of 5-HT2A receptors in mild mesenteric ischemia/reperfusion dysfunctions in micePharmacological Research, 2007
- DAMGO and 6β-glycine substituted 14-O-methyloxymorphone but not morphine show peripheral, preemptive antinociception after systemic administration in a mouse visceral pain model and high intrinsic efficacy in the isolated rat vas deferensBrain Research Bulletin, 2007
- Protective Effect of Proteinase-Activated Receptor 2 Activation on Motility Impairment and Tissue Damage Induced by Intestinal Ischemia/Reperfusion in RodentsThe American Journal of Pathology, 2006
- T-Lymphocytes Modulate the Microvascular and Inflammatory Responses to Intestinal Ischemia-ReperfusionMicrocirculation, 2002
- T-Lymphocytes Modulate the Microvascular and Inflammatory Responses to Intestinal Ischemia-ReperfusionMicrocirculation, 2002
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001
- Opioid and Opiate Immunoregulatory ProcessesCritical Reviews in Immunology, 1996
- Accurate measurement of intestinal transit in the ratJournal of Pharmacological Methods, 1981